AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.680
-0.020 (-0.74%)
Dec 20, 2024, 4:00 PM EST - Market closed
AC Immune Market Cap
AC Immune has a market cap or net worth of $265.16 million as of December 20, 2024. Its market cap has decreased by -12.31% in one year.
Market Cap
265.16M
Enterprise Value
81.89M
1-Year Change
-12.31%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $265.16M, a decrease of -69.43%. That is a compound annual growth rate of -13.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| COMPASS Pathways | 268.21M |
| Zynex | 267.50M |
| Accolade | 267.38M |
| ProQR Therapeutics | 267.30M |
| 4D Molecular Therapeutics | 267.20M |
| Senseonics Holdings | 266.83M |
| aTyr Pharma | 264.42M |
| Atea Pharmaceuticals | 264.37M |